TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Hematuria Treatment Market – By Treatment

1.3.2        North America Hematuria Treatment Market – By Indication

1.3.3        North America Hematuria Treatment Market – By Type

1.3.4        North America Hematuria Treatment Market – By End User

1.3.5        North America Hematuria Treatment Market – By Country

2.           North America Hematuria Treatment Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Hematuria Treatment Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America – PEST Analysis

4.3         Experts Opinion

5.           Hematuria Treatment Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        High Prevalence of Hematuria-Associated Indications

5.1.2        Increasing Awareness About Treatment Options and Improving Healthcare Expenditure

5.2         Market Restraints

5.2.1        Undiagnosed Cases of Associated Indications

5.3         Market Opportunities

5.3.1        Increasing Opportunities for Related Treatments

5.4         Future Trends

5.4.1        Rise in Preference for Advanced Therapies

5.5         Impact Analysis

6.           Hematuria Treatment Market – North America Analysis

6.1         North America Hematuria Treatment Market Revenue Forecast and Analysis

7.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment

7.1         Overview

7.2         North America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

7.3         Drugs

7.3.1        Overview

7.3.2        Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Therapies

7.4.1        Overview

7.4.2        Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.5         Others

7.5.1        Overview

7.5.2        Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication

8.1         Overview

8.2         North America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

8.3         Kidney Stones

8.3.1        Overview

8.3.2        Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Urinary Tract Infections (UTI)

8.4.1        Overview

8.4.2        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Urethritis

8.5.1        Overview

8.5.2        Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Blood Cancer

8.6.1        Overview

8.6.2        Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Bladder Stones

8.7.1        Overview

8.7.2        Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Prostate Cancer

8.8.1        Overview

8.8.2        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.9         Cystitis

8.9.1        Overview

8.9.2        Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.10      Trauma

8.10.1     Overview

8.10.2     Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.11      Vigorous Exercise

8.11.1     Overview

8.11.2     Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.12      Polycystic Kidney Disease

8.12.1     Overview

8.12.2     Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.13      Endometriosis

8.13.1     Overview

8.13.2     Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.14      Menstruation

8.14.1     Overview

8.14.2     Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

9.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Type

9.1         Overview

9.2         North America Hematuria Treatment Market, By Type 2020 & 2028 (%)

9.3         Macroscopic Hematuria

9.3.1        Overview

9.3.2        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.4         Microscopic Hematuria

9.4.1        Overview

9.4.2        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.5         Idiopathic Hematuria

9.5.1        Overview

9.5.2        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.6         Jogger’s Hematuria

9.6.1        Overview

9.6.2        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

10.        Hematuria Treatment Market Revenue and Forecast To 2028 – By End User

10.1      Overview

10.2      North America Hematuria Treatment Market Share by End User 2020 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.4      Clinics

10.4.1     Overview

10.4.2     Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.5      Ambulatory Surgical Centers (ASC’s)

10.5.1     Overview

10.5.2     Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.6      Others

10.6.1     Overview

10.6.2     Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

11.        North America Hematuria Treatment Market – Geographic Analysis

11.1      North America: Hematuria Treatment Market

11.1.1     Overview

11.1.2     North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)

11.1.2.1       US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.1       US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.2       US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.3       US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.4       US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.5       US: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.2.2       Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.1       Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.2       Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.3       Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.4       Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.5       Canada: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.2.3       Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.1       Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.2       Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.3       Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.4       Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.5       Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

12.        Impact Of COVID-19 Pandemic on Hematuria Treatment Market

12.1      North America: Impact Assessment of COVID-19 Pandemic

13.        Hematuria Treatment Market–Industry Landscape

13.1      Overview

13.2      Growth Strategies Done by the Companies in the Market, (%)

13.3      Organic Developments

13.3.1     Overview

13.4      Inorganic Developments

13.4.1     Overview

14.        Company Profiles

14.1      AstraZeneca

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Bristol-Myers Squibb Company

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      F. HOFFMANN-LA ROCHE LTD.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      GlaxoSmithKline Plc

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Janssen Pharmaceuticals

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Merck & Co., Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Novartis AG

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Pfizer Inc.

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Sun Pharmaceutical Industries Ltd

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   Boehringer Ingelheim International GmbH

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 2.             US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 3.             US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 4.             US: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 5.             Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 6.             Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 7.             Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Canada: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 9.             Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 10.          Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 11.          Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          Organic Developments Done by Companies

Table 14.          Inorganic Developments Done by Companies

Table 15.          Glossary of Terms, Hematuria Treatment Market

LIST OF FIGURES

Figure 1.           Hematuria Treatment Market Segmentation

Figure 2.           North America Hematuria Treatment Market Overview

Figure 3.           Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market

Figure 4.           US to Show Significant Growth During Forecast Period

Figure 5.           North America Hematuria Treatment Market, Industry Landscape

Figure 6.           North America PEST Analysis

Figure 7.           Hematuria Treatment Market Impact Analysis of Drivers and Restraints

Figure 8.           North America Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           North America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

Figure 10.        Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 11.        Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 12.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 13.        North America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

Figure 14.        Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 15.        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 16.        Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 17.        Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 18.        Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 19.        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 20.        Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 21.        Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 22.        Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 23.        Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 24.        Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 25.        Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 26.        North America Hematuria Treatment Market, by Type 2020 & 2028 (%)

Figure 27.        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 28.        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 29.        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 30.        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 31.        North America Hematuria Treatment Market Share by End User 2020 & 2028 (%)

Figure 32.        Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 33.        Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 34.        Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 35.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 36.        North America: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)

Figure 37.        North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)

Figure 38.        US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 41.        Impact Of COVID-19 Pandemic in North America Country Markets

Figure 42.        Growth Strategies Done by the Companies in the Market, (%)